<VariationArchive VariationID="1048502" VariationName="NM_000512.5(GALNS):c.1319del (p.Leu440fs)" VariationType="Deletion" Accession="VCV001048502" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-17" DateCreated="2021-08-25" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1036148" VariationID="1048502">
      <GeneList>
        <Gene Symbol="GALNS" FullName="galactosamine (N-acetyl)-6-sulfatase" GeneID="2588" HGNC_ID="HGNC:4122" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88813734" stop="88856947" display_start="88813734" display_stop="88856947" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88880141" stop="88923373" display_start="88880141" display_stop="88923373" Strand="-" />
          </Location>
          <OMIM>612222</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000512.5(GALNS):c.1319del (p.Leu440fs)</Name>
      <CanonicalSPDI>NC_000016.10:88822633:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88822634" stop="88822634" display_start="88822634" display_stop="88822634" variantLength="1" positionVCF="88822633" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88889042" stop="88889042" display_start="88889042" display_stop="88889042" variantLength="1" positionVCF="88889041" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L255fs</ProteinChange>
      <ProteinChange>L440fs</ProteinChange>
      <ProteinChange>L446fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88822634del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88822634del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88889042del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88889042del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008667.1" sequenceAccession="NG_008667" sequenceVersion="1" change="g.39333del">
            <Expression>NG_008667.1:g.39333del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000512.5" sequenceAccession="NM_000512" sequenceVersion="5" change="c.1319del" MANESelect="true">
            <Expression>NM_000512.5:c.1319del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000503.1" sequenceAccession="NP_000503" sequenceVersion="1" change="p.Leu440fs">
            <Expression>NP_000503.1:p.Leu440fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001323543.2" sequenceAccession="NM_001323543" sequenceVersion="2" change="c.764del">
            <Expression>NM_001323543.2:c.764del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001310472.1" sequenceAccession="NP_001310472" sequenceVersion="1" change="p.Leu255fs">
            <Expression>NP_001310472.1:p.Leu255fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001323544.2" sequenceAccession="NM_001323544" sequenceVersion="2" change="c.1337del">
            <Expression>NM_001323544.2:c.1337del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001310473.1" sequenceAccession="NP_001310473" sequenceVersion="1" change="p.Leu446fs">
            <Expression>NP_001310473.1:p.Leu446fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="612222.0017" DB="OMIM" />
        <XRef Type="rs" ID="1567517083" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000512.5(GALNS):c.1319del (p.Leu440fs) AND Mucopolysaccharidosis, MPS-IV-A" Accession="RCV001578608" Version="8">
        <ClassifiedConditionList TraitSetID="175">
          <ClassifiedCondition DB="MedGen" ID="C0086651">Mucopolysaccharidosis, MPS-IV-A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-17" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-17" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-08-25" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12721840</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16287098</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24035930</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24726177</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34387910</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7633425</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="175" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3036" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MPS 4A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio A disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosamine-6-sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A, mild</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-IV-A</ElementValue>
                <XRef ID="Morquio+syndrome+A/4876" DB="Genetic Alliance" />
                <XRef ID="7259005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IV A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis Type IVA</ElementValue>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS IVA</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS4A</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3785" />
                <XRef ID="3785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of mucopolysaccharidosis IVA (MPS IVA) is a continuum that ranges from a severe and rapidly progressive early-onset form to a slowly progressive later-onset form. Children with MPS IVA typically have no distinctive clinical findings at birth. The severe form is usually apparent between ages one and three years, often first manifesting as kyphoscoliosis, genu valgum (knock-knee), and pectus carinatum; the slowly progressive form may not become evident until late childhood or adolescence, often first manifesting as hip problems (pain, stiffness, and Legg Perthes disease). Progressive bone and joint involvement leads to short stature, and eventually to disabling pain and arthritis. Involvement of other organ systems can lead to significant morbidity, including respiratory compromise, obstructive sleep apnea, valvular heart disease, hearing impairment, visual impairment from corneal clouding, dental abnormalities, and hepatomegaly. Compression of the spinal cord is a common complication that results in neurologic impairment. Children with MPS IVA have normal intellectual abilities at the outset of the disease.</Attribute>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23844448</ID>
                <ID Source="BookShelf">NBK148668</ID>
              </Citation>
              <XRef ID="309297" DB="Orphanet" />
              <XRef ID="582" DB="Orphanet" />
              <XRef ID="C0086651" DB="MedGen" />
              <XRef ID="MONDO:0009659" DB="MONDO" />
              <XRef Type="MIM" ID="253000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20897" SubmissionDate="2015-09-28" DateLastUpdated="2015-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612222.0017_MUCOPOLYSACCHARIDOSIS, TYPE IVA" title="GALNS, 1-BP DEL, 1374T_MUCOPOLYSACCHARIDOSIS, TYPE IVA" />
        <ClinVarAccession Accession="SCV000020897" DateUpdated="2015-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">See 612222.0014 and Montano et al. (2003).</Attribute>
              <Citation>
                <ID Source="PubMed">12721840</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNS" />
          </GeneList>
          <Name>GALNS, 1-BP DEL, 1374T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1374T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612222.0017" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MUCOPOLYSACCHARIDOSIS, TYPE IVA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3047948" SubmissionDate="2021-10-28" DateLastUpdated="2021-10-30" DateCreated="2021-08-25">
        <ClinVarSubmissionID localKey="NM_000512.5:c.1319del|OMIM:253000" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001547950" DateUpdated="2021-10-30" DateCreated="2021-08-25" Type="SCV" Version="3" SubmitterName="Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova" OrgID="506414" OrganizationCategory="laboratory" OrgAbbreviation="LAB-DTLD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12721840</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16287098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24035930</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24726177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7633425</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34387910</ID>
          </Citation>
          <Comment>Frameshift variant (PVS1_strong); the prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls (PS4_strong); very low frequency in gnomAD v2.1.1 (PM2_moderate)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="5" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="778286877" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000512.5:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10295861</SubmissionName>
          <SubmissionName>SUB10583943</SubmissionName>
          <SubmissionName>SUB9123788</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3967118" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="76729ae5933785e150859db6e1e3ba78443debc70017360ab580a909662029ab|OMIM:253000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024149" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000512.5:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3047948" TraitType="Disease" MappingType="XRef" MappingValue="253000" MappingRef="OMIM">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3967118" TraitType="Disease" MappingType="XRef" MappingValue="253000" MappingRef="OMIM">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20897" TraitType="Disease" MappingType="Name" MappingValue="MUCOPOLYSACCHARIDOSIS, TYPE IVA" MappingRef="Preferred">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

